GSK inks $1 billion cancer drug deal

Stephen McGuire

October 11 2007

GlaxoSmithKline said it is acquiring the rights to Synta Pharmaceuticals' skin cancer drug STA-4783 in a deal worth up to ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.